Loading…
Reported covered position: Legislative Assistant, Rep. Glenn Grothman (R-WI)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Vaccine Access Improvement Act of 2019
Client: NOVAVAX · Firm: FAEGRE BAKER DANIELS CONSULTING
Vaccine policy issues; H.R. 1973 - Vaccine Access Improvement Act of 2019
Safe Step Act
Client: THE CROHN'S & COLITIS FOUNDATION · Firm: FAEGRE BAKER DANIELS CONSULTING
H.R. 2279 and S.2546 - Safe Step Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MEDICAL TRANSPORTATION ACCESS COALITION via FAEGRE BAKER DANIELS CONSULTING
2020 · first_quarter · 1T
Legislation and policies impacting beneficiary access to non-emergency medical transportation issues; H.R. 3935, S. 2846 - Protecting Patients Transportation to Care Act
Fiscal Year 2021 Labor HHS Appropriations Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Protecting Patients Transportation to Care Act
Client: MEDICAL TRANSPORTATION ACCESS COALITION · Firm: FAEGRE BAKER DANIELS CONSULTING
Legislation and policies impacting beneficiary access to non-emergency medical transportation issues; H.R. 3935, S. 2846 - Protecting Patients Transportation to Care Act
Safe Step Act
Client: THE CROHN'S & COLITIS FOUNDATION · Firm: FAEGRE BAKER DANIELS CONSULTING
H.R. 2279 and S.2546 - Safe Step Act
Protecting Patients Transportation to Care Act
Client: MEDICAL TRANSPORTATION ACCESS COALITION · Firm: FAEGRE BAKER DANIELS CONSULTING
Legislation and policies impacting beneficiary access to non-emergency medical transportation issues; H.R. 3935, S. 2846 - Protecting Patients Transportation to Care Act
Safe Step Act
Client: THE CROHN'S & COLITIS FOUNDATION · Firm: FAEGRE BAKER DANIELS CONSULTING
H.R. 2279 and S.2546 - Safe Step Act; H.R. 2501 Medical Nutrition Equity Act of 2019; Re-authorization of PCORI
Safe Step Act
Client: THE CROHN'S & COLITIS FOUNDATION · Firm: FAEGRE BAKER DANIELS CONSULTING
H.R. 2279 and S.2546 - Safe Step Act; H.R. 2501 Medical Nutrition Equity Act of 2019; Re-authorization of PCORI
Safe Step Act
Client: THE CROHN'S & COLITIS FOUNDATION · Firm: FAEGRE BAKER DANIELS CONSULTING
HR 2279 - Safe Step Act; HR 2501 Medical Nutrition Equity Act of 2019; Reauthorization of PCORI
Medical Nutrition Equity Act of 2019
Client: THE CROHN'S & COLITIS FOUNDATION · Firm: FAEGRE BAKER DANIELS CONSULTING
H.R. 2279 and S.2546 - Safe Step Act; H.R. 2501 Medical Nutrition Equity Act of 2019; Re-authorization of PCORI
Medical Nutrition Equity Act of 2019
Client: THE CROHN'S & COLITIS FOUNDATION · Firm: FAEGRE BAKER DANIELS CONSULTING
HR 2279 - Safe Step Act; HR 2501 Medical Nutrition Equity Act of 2019; Reauthorization of PCORI
Medical Nutrition Equity Act of 2019
Client: THE CROHN'S & COLITIS FOUNDATION · Firm: FAEGRE BAKER DANIELS CONSULTING
H.R. 2279 and S.2546 - Safe Step Act; H.R. 2501 Medical Nutrition Equity Act of 2019; Re-authorization of PCORI
Safe Step Act
Client: THE CROHN'S & COLITIS FOUNDATION · Firm: FAEGRE BAKER DANIELS CONSULTING
H.R. 2279 and S.2546 - Safe Step Act; H.R. 2501 Medical Nutrition Equity Act of 2019; Re-authorization of PCORI
Safe Step Act
Client: THE CROHN'S & COLITIS FOUNDATION · Firm: FAEGRE BAKER DANIELS CONSULTING
H.R. 2279 and S.2546 - Safe Step Act; H.R. 2501 Medical Nutrition Equity Act of 2019; Re-authorization of PCORI
2020 · first_quarter · 1T
H.R. 2279 and S.2546 - Safe Step Act
FY 2021 Appropriations including support for medical research at NIH, public health activities at CDC, research funding at DoD, and therapy development at FDA; Issues pertaining to response to COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
NOVAVAX via FAEGRE BAKER DANIELS CONSULTING
2020 · first_quarter · 1T
Vaccine policy issues; H.R. 1973 - Vaccine Access Improvement Act of 2019
Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE CROHN'S & COLITIS FOUNDATION via FAEGRE BAKER DANIELS CONSULTING
2019 · fourth_quarter · Q4
Fiscal Year 2020 Labor HHS appropriations; funding for CDC, NIH and DOD focused on inflammatory bowel diseases; NIH support for inflammatory bowel disease research; FDA policies on pediatric therapy development.
H.R. 2279 and S.2546 - Safe Step Act; H.R. 2501 Medical Nutrition Equity Act of 2019; Re-authorization of PCORI
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
THE CROHN'S & COLITIS FOUNDATION via FAEGRE BAKER DANIELS CONSULTING
2019 · third_quarter · Q3
Fiscal Year 2020 Labor HHS appropriations; funding for CDC, NIH and DOD focused on inflammatory bowel diseases; NIH support for inflammatory bowel disease research; FDA policies on pediatric therapy development.
H.R. 2279 and S.2546 - Safe Step Act; H.R. 2501 Medical Nutrition Equity Act of 2019; Re-authorization of PCORI
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
THE CROHN'S & COLITIS FOUNDATION via FAEGRE BAKER DANIELS CONSULTING
2019 · second_quarter · Q2
HR 2279 - Safe Step Act; HR 2501 Medical Nutrition Equity Act of 2019; Reauthorization of PCORI
Fiscal Year 2020 Labor HHS appropriations; funding for CDC, NIH and DOD focused on inflammatory bowel diseases; NIH support for inflammatory bowel disease research; FDA policies on pediatric therapy development.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE